Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Aytu Biopharma Inc (AYTU)

Aytu Biopharma Inc (AYTU)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aytu Biopharma Inc 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 USA

P: 720-437-6580

Description:

Aytu BioScience, Inc. is a healthcare company which focused on commercialization of novel products in the field of urology. The company's marketed products consists of ProstaScint(R), Primsol(R) and MiOXSYS(TM) which addresses prostate cancer, urinary tract infections, male infertility and male sexual dysfunction. Aytu BioScience, Inc. is based in Englewood, Colorado.

Key Statistics

Overview:

Market Capitalization, $K 78,785
Shares Outstanding, K 25,171
Annual Sales, $ 27,630 K
Annual Net Income, $ -13,620 K
Last Quarter Sales, $ 13,480 K
Last Quarter Net Income, $ -25,460 K
60-Month Beta -0.28
% of Insider Shareholders 6.60%
% of Institutional Shareholders 26.96%
Float, K 23,510
% Float 93.40%

Growth:

1-Year Return -77.32%
3-Year Return -88.82%
5-Year Return -99.98%
5-Year Revenue Growth 10,526.92%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 09/13/21
Earnings Per Share ttm -1.04
EPS Growth vs. Prev Qtr 63.83%
EPS Growth vs. Prev Year 88.67%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 12/09/20

AYTU Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 0.00
Price/Earnings to Growth N/A
Return-on-Equity % -15.03%
Return-on-Assets % -9.07%
Profit Margin % -49.29
Net Margin % N/A
Debt/Equity 0.18
Price/Sales 0.75
Price/Cash Flow N/A
Price/Book 0.61
Book Value/Share 6.10
Interest Coverage -4.22
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar